Comment
. 2006 Sep;45(9):1176-7; author reply 1177-8.
doi: 10.1093/rheumatology/kel181.
Epub 2006 Jul 4.
BSR guidelines for TNF blockers in ankylosing spondylitis--how useful are they?
- PMID: 16820380
- DOI: 10.1093/rheumatology/kel181
Item in Clipboard
Comment
BSR guidelines for TNF blockers in ankylosing spondylitis--how useful are they?
Rheumatology (Oxford).
2006 Sep.
No abstract available
Comment on
-
BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology.Rheumatology (Oxford). 2005 Jul;44(7):939-47. doi: 10.1093/rheumatology/keh669. Epub 2005 May 18. Rheumatology (Oxford). 2005. PMID: 15901904 No abstract available.
Similar articles
-
The impact of the NICE appraisal consultation document on anti-TNF therapy for ankylosing spondylitis.Rheumatology (Oxford). 2007 Jun;46(6):1044-5. doi: 10.1093/rheumatology/kem065. Epub 2007 Mar 31. Rheumatology (Oxford). 2007. PMID: 17401132 No abstract available.
-
Characteristics and treatment responses of patients satisfying the BSR guidelines for anti-TNF in ankylosing spondylitis.Rheumatology (Oxford). 2007 Mar;46(3):439-41. doi: 10.1093/rheumatology/kel430. Epub 2007 Jan 25. Rheumatology (Oxford). 2007. PMID: 17255137 Clinical Trial.
-
Predictors of response to tumor necrosis factor-alpha blockers in ankylosing spondylitis.J Rheumatol. 2005 Sep;32(9):1637-40. J Rheumatol. 2005. PMID: 16142852 No abstract available.
-
Treatment of ankylosing spondylitis in patients refractory to TNF-inhibition: are there alternatives?Curr Opin Rheumatol. 2012 May;24(3):252-60. doi: 10.1097/BOR.0b013e3283524b82. Curr Opin Rheumatol. 2012. PMID: 22450391 Review.
-
Recognition and treatment of juvenile-onset spondyloarthritis.Curr Opin Rheumatol. 2006 Sep;18(5):507-11. doi: 10.1097/01.bor.0000240363.09218.61. Curr Opin Rheumatol. 2006. PMID: 16896291 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
